STOCK TITAN
  1. Home
  2. Sec-filings
  3. UNH
  4. [8-K] UNITEDHEALTH GROUP INC Reports Material Event

UnitedHealth Group (NYSE: UNH) leaders to speak at Barclays Global Healthcare

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

UnitedHealth Group Incorporated announced that senior leaders will participate in a question-and-answer interview at the Barclays 28th Annual Global Healthcare Conference. They plan to discuss the company’s strategy, market positions, recent results and expectations for its end markets. A live audio webcast will be available through the investor relations section of the company’s website.

Positive

  • None.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Understanding 8-K Material Events →
0000731766false00007317662026-03-092026-03-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
—————————————
FORM 8-K
—————————————
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 9, 2026
—————————————
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter)
—————————————
Delaware1-1086441-1321939
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
1 Health Drive655 New York Avenue NW
Eden Prairie,Minnesota55344Washington,DC20001
(Address of principal executive offices)(Zip Code)(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (800) 328-5979
N/A
(Former name or former address, if changed since last report.)
—————————————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $.01 par valueUNHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 7.01    Regulation FD Disclosure.

Senior leaders from UnitedHealth Group Incorporated (the "Company") will respond to questions in an interview format, including discussion of the Company’s strategy, market positions, recent results and expectations for its end markets, at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, beginning at 11:30 a.m., Eastern Time.

A live audio webcast of the presentation will be made available through the Investor Relations page of the Company’s website at www.unitedhealthgroup.com.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 9, 2026                 
UNITEDHEALTH GROUP INCORPORATED
By: /s/ Kuai H. Leong
Kuai H. Leong
Senior Deputy General Counsel and
Deputy Corporate Secretary

Source: View Original Filing on SEC EDGAR

FAQ

What event is UnitedHealth Group (UNH) participating in according to this 8-K?

UnitedHealth Group will participate in the Barclays 28th Annual Global Healthcare Conference. Senior leaders will take part in an interview-format session covering the company’s strategy, market positions, recent results and expectations for its end markets.

When will UnitedHealth Group’s Barclays conference presentation take place?

The presentation is scheduled for Tuesday, March 10, 2026, beginning at 11:30 a.m. Eastern Time. Senior leaders will respond to questions in an interview format during this session at the Barclays 28th Annual Global Healthcare Conference.

What topics will UnitedHealth Group (UNH) discuss at the Barclays conference?

UnitedHealth Group leaders will discuss the company’s strategy, market positions, recent results and expectations for its end markets. These topics will be addressed in an interview-style session during the Barclays 28th Annual Global Healthcare Conference.

How can investors access UnitedHealth Group’s Barclays conference presentation?

A live audio webcast of the presentation will be available via the Investor Relations page of UnitedHealth Group’s website at www.unitedhealthgroup.com. This allows investors and stakeholders to listen to the interview in real time.

Is the information from this UnitedHealth Group presentation considered filed with the SEC?

The company states that the information in this Regulation FD disclosure section shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, or incorporated by reference into other securities law filings, unless expressly referenced.

Filing Exhibits & Attachments

4 documents

Other Documents